Bartonella in Liver Transplant Patients

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2021

Conditions
Cryptogenic CirrhosisCryptogenic Chronic Hepatitis
Interventions
OTHER

skin punch biopsy collection

Four-mm skin biopsies from non-lesional skin will be acquired from the patients, processed using our published techniques with Bartonella biomarkers, and imaged using confocal microscopy.

OTHER

Blood collection

Blood will be tested for presence of Bartonella DNA and Bartonella antibodies using the Alpha Proteobacterium Growth Medium (BAPGM) multi-platform testing, including liquid culture, enriched agar plating and molecular techniques.Blood smears will be analyzed for presence of intra-erythrocytic Bartonella spp. by immunostaining.

OTHER

Urine sample collection

Urine samples will be collected and analyzed for Bartonella spp specific microRNAs.

Trial Locations (1)

55455

University of Minnesota Medical Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02595710 - Bartonella in Liver Transplant Patients | Biotech Hunter | Biotech Hunter